The Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.

Saudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.

BMJ Open Ophthalmology is an esteemed, open-access journal dedicated to the field of ophthalmology, published by the renowned BMJ Publishing Group. Established in 2016, this journal has quickly made its mark within the ophthalmology community, achieving a respectable Q2 ranking in the 2023 category quartiles. It is indexed in Scopus, boasting a commendable ranking of **#52** out of **137** in the medicine discipline of ophthalmology, placing it in the **62nd percentile**. This global platform is committed to disseminating high-quality research, clinical studies, and innovative practices that propel the understanding and treatment of eye diseases. With its open access model, BMJ Open Ophthalmology ensures that vital research is readily available to health professionals, researchers, and students, fostering collaboration and advancing knowledge within the field. The journal is based in London, United Kingdom, and continues to welcome submissions that explore the latest advancements in ophthalmic science, contributing to enhanced patient care and outcomes.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.

Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.

Japanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.

Ophthalmic Research, with ISSN 0030-3747 and E-ISSN 1423-0259, is a distinguished peer-reviewed journal published by Karger in Switzerland. Established in 1970, this journal serves as a vital resource for exploration and dissemination of knowledge within the fields of Ophthalmology, Cellular and Molecular Neuroscience, and Sensory Systems, maintaining its relevance through its convergence into modern research methodologies leading up to 2024. With impressive rankings in 2023, it holds a Q2 quartile in both Ophthalmology and Medicine (miscellaneous), reflecting its significant contribution to the academic community, alongside Scopus ranks that position it favorably in the competitive landscape of medical and neuroscientific literature. Although not open access, the journal ensures that high-quality research remains accessible to its readership, which includes researchers, professionals, and students eager to stay at the forefront of ophthalmic advancements. By fostering interdisciplinary collaboration and facilitating high-level discourse, Ophthalmic Research is pivotal for those committed to advancing the future of eye care and vision sciences.

INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.